FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON Share Price

Certificat

DE000MF1HF20

Market Closed - Börse Stuttgart 20:56:48 20/05/2024 BST
3.86 EUR -5.39% Intraday chart for FAKTOR-OPTIONSSCHEIN - JOHNSON & JOHNSON
Current month+17.33%
1 month+6.93%
Date Price Change
20/05/24 3.86 -5.39%
17/05/24 4.08 +1.75%
16/05/24 4.01 +2.56%
15/05/24 3.91 +3.17%
14/05/24 3.79 +0.26%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 08:56 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer Morgan Stanley
WKN MF1HF2
ISINDE000MF1HF20
Date issued 06/02/2017
Strike 115.4 $
Maturity Unlimited
Parity 8.61 : 1
Emission price 10
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 23.07
Lowest since issue 2.91

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.3 USD
Average target price
173.3 USD
Spread / Average Target
+14.54%
Consensus